| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.9M | -35.6% | +34.3% |
| Cost of Revenue | $872K | -34.2% | +41.6% |
| Gross Profit | $990K | -36.8% | +28.4% |
| R&D Expense | $1.5M | +5.6% | -2.8% |
| SG&A Expense | $1.9M | +1.8% | -1.1% |
| Operating Income | -$2.4M | -40.4% | +10.6% |
| Pre-tax Income | -$2.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.8M | -21.3% | +112.4% |
| Accounts Receivable | $1.9M | -28.7% | +495.2% |
| Inventory | $2.1M | +26.0% | +14.4% |
| Current Assets | $7.1M | -11.9% | +89.3% |
| Total Assets | $7.6M | -11.8% | +69.8% |
| Current Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | -42.6% | — |
| Capital Expenditures | $79K | +94.5% | — |
| Investing Cash Flow | -$79K | -94.5% | — |
| Financing Cash Flow | $757K | +412.4% | — |
| Free Cash Flow | -$4.5M | -43.3% | — |
| -65.7% |
| -4.9% |
| Net Income | -$2.4M | -65.7% | -4.9% |
| EPS (Basic) | -$0.28 | -833.3% | -300.0% |
| EPS (Diluted) | -$0.28 | -833.3% | -300.0% |
| $1.7M |
| +34.2% |
| -4.2% |
| Total Liabilities | $2.5M | +14.5% | -25.2% |
| Stockholders' Equity | $5.1M | -20.7% | +351.0% |